Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Sher Bahadur
Institutions:
Dana-Farber/Boston Children's Cancer and Blood Disorders Center,
Weill Cornell Medicine
Observed institutions:
Broad Institute,
Cornell University,
Dana-Farber Cancer Institute,
Dana-Farber/Boston Children's Cancer and Blood Disorders Center,
Weill Cornell Medicine
ORCID:
0009-0007-6362-4151
Observed ORCID:
0009-0007-6362-4151
OpenAlex ID:
A5106821053
A diverse landscape of FGFR alterations and co-mutations suggests potential therapeutic strategies in pediatric low-grade gliomas
2025
·
April A. Apfelbaum
, Eric Morin
, et al.
·
Nature Communications
·
22
PDF
O-mannosylation and protein maturation checkpoints represent therapeutic opportunities in BRAF fusion protein oncogenesis
2026
·
Anna Borgenvik
, Sean A. Misek
, et al.
·
Cancer Discovery
·
3
A selective TNKS2 inhibitor for tumor-restricted WNT suppression
2026
·
Jill Zimmerman
, Brandon F. Malone
, et al.
·
Nature Chemical Biology
·
1
PDF
Author Correction: A diverse landscape of FGFR alterations and co-mutations suggests potential therapeutic strategies in pediatric low-grade gliomas
2025
·
April A. Apfelbaum
, Eric Morin
, et al.
·
Nature Communications
·
1
PDF
Abstract B009: Cancer-associated fibroblasts remodel the extracellular matrix in Adamantinomatous Craniopharyngioma
2025
·
Timothy H Chang
, Shriya M Rangaswamy
, et al.
·
Cancer Research
Abstract B020: Preclinical investigation of FGFR inhibitors in pediatric low-grade gliomas
2025
·
April A Apfelbaum
, Sangita Pal
, et al.
·
Cancer Research
Show more works
View as search
Works count:
6
Citation count:
27
H-index:
2
I10-index:
1
Year
Topic
Type